Cytokinetics Inc (CYTK)

Oct 21, 2026

Cytokinetics to Announce Third Quarter Results on November 4, 2026 - GlobeNewswire Inc.

Oct 21, 2026

Oct 20, 2026

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Oct 20, 2026

Oct 20, 2026

Form 4 Cytokinetics Inc: Nancy Wysenski (Director) For: 16 October By Investing.com - Investing.com Canada

Oct 20, 2026

Oct 20, 2026

195 shares replace a cash retainer for Cytokinetics (CYTK) director Edward M. Kaye. - Stock Titan

Oct 20, 2026

Oct 20, 2026

A 195-share award brings Harrington's direct Cytokinetics (CYTK) holdings to 22,127 shares. - Stock Titan

Oct 20, 2026

Oct 20, 2026

Cytokinetics Director Wendell Wierenga Purchases 97 Shares at $63.92 Each - Kalkine Media

Oct 20, 2026

Oct 20, 2026

Shares replace a cash retainer as Cytokinetics (CYTK) director Henderson receives 352 shares. - Stock Titan

Oct 20, 2026

Oct 20, 2026

Officer Fady Malik proposes selling 16,386 Cytokinetics (CYTK) shares from option exercises. - Stock Titan

Oct 20, 2026

Oct 20, 2026

RBC Capital Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $113 - Moomoo

Oct 20, 2026

Oct 19, 2026

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Oct 19, 2026

Oct 19, 2026

29 new hires at Cytokinetics received stock awards. Share awards vest over 3 years; options over 4. - Stock Titan

Oct 19, 2026

Oct 19, 2026

BridgeBio, Madrigal, Cytokinetics Trade Lower Ahead of Q3 Results Amid Lack of Near-Term Catalysts, BofA Says - www.marketscreener.com

Oct 19, 2026

Oct 19, 2026

BridgeBio, Madrigal, Cytokinetics Trade Lower Ahead of Q3 Results Amid Lack of Near-Term Catalysts, BofA Says - Yahoo Finance

Oct 19, 2026

Oct 19, 2026

CYTK Reiterates by HC Wainwright & Co. -- Price Target Maintained at $140 - GuruFocus

Oct 19, 2026

Oct 19, 2026

HC Wainwright & Co. reiterates Buy rating on Cytokinetics, $140 price target - TradingView

Oct 19, 2026

Oct 19, 2026

Can Myqorzo's Expansion and Growing Adoption Drive CYTK's Growth? - Yahoo Finance

Oct 19, 2026

Oct 19, 2026

BofA Securities Adjusts Price Target on Cytokinetics to $81 From $85, Maintains Neutral Rating - Yahoo Finance

Oct 19, 2026

Oct 19, 2026

Canada authorizes a drug for adults whose thickened heart muscle blocks blood flow - Stock Titan

Oct 19, 2026

Oct 19, 2026

Cytokinetics Announces Health Canada Approval of MYQORZO® - GlobeNewswire

Oct 19, 2026

Oct 16, 2026

CYTK Initiated Coverage by William Blair -- Rating Set to Outper - GuruFocus

Oct 16, 2026

Oct 16, 2026

William Blair Initiates Coverage on Cytokinetics With Outperform Rating - Yahoo Finance

Oct 16, 2026

Oct 15, 2026

William Blair initiates Cytokinetics stock coverage with outperform rating By Investing.com - Investing.com South Africa

Oct 15, 2026

Oct 15, 2026

William Blair initiates Cytokinetics stock coverage with outperform rating - Investing.com

Oct 15, 2026

Oct 15, 2026

Here's How Much $1000 Invested In Cytokinetics 15 Years Ago Would Be Worth Today - Benzinga

Oct 15, 2026

Oct 15, 2026

Cytokinetics, Incorporated (CYTK) Stock forecasts - Yahoo Finance UK

Oct 15, 2026

Oct 15, 2026

Cytokinetics Sees Myqorzo Launch Strength Carry Into 2027, RBC Says - marketscreener.com

Oct 15, 2026

Oct 15, 2026

Cytokinetics (NasdaqGS:CYTK) Stock Forecast & Analyst Predictions - Simply Wall Street

Oct 15, 2026

Oct 14, 2026

Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo Finance

Oct 14, 2026

Oct 14, 2026

UBS cuts Cytokinetics stock price target on valuation, keeps Buy - Investing.com

Oct 14, 2026

Oct 13, 2026

Cytokinetics Insider Sold Shares Worth $471,600, According to a Recent SEC Filing - Yahoo Finance

Oct 13, 2026

Oct 13, 2026

A $1.42M proposed share sale at Cytokinetics (CYTK) draws on Robert Blum’s stock options. - Stock Titan

Oct 13, 2026

Oct 13, 2026

Cytokinetics (CYTK), What Is Behind The Fresh Attention? - Yahoo Finance

Oct 13, 2026

Oct 12, 2026

Cytokinetics (CYTK) Stock Looks Hard To Pin Down Following Strong Heart Drug Updates - Yahoo Finance

Oct 12, 2026

Oct 12, 2026

Cytokinetics (CYTK) Reports Phase 3 Aficamten Gains In Non Obstructive HCM - Yahoo Finance

Oct 12, 2026

Oct 12, 2026

Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo Finance

Oct 12, 2026

Oct 12, 2026

Cytokinetics presents additional aficamten data from trial - Investing.com

Oct 12, 2026

Oct 12, 2026

Serious heart failure events affected 4.7% taking aficamten, versus 1.2% on placebo. - Stock Titan

Oct 12, 2026

Oct 12, 2026

Cytokinetics Q2 2026 Earnings Call: Complete Transcript - Benzinga

Oct 12, 2026

Oct 11, 2026

Cytokinetics EVP Fady Malik sells $214,830 in company stock - Investing.com

Oct 11, 2026

Oct 11, 2026

Form 4 Cytokinetics Inc For: 11 October By Investing.com - Investing.com Nigeria

Oct 11, 2026

Oct 08, 2026

CYTK6536068 Bond Yield and Price — FINRA:CYTK6536068 - TradingView

Oct 08, 2026

Oct 07, 2026

Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo Finance

Oct 07, 2026

Oct 06, 2026

Cytokinetics Inc (CYTK) EVP Research & Development Fady Malik Se - GuruFocus

Oct 06, 2026

Oct 06, 2026

Cytokinetics (CYTK): Company Profile, Stock Price, News, Rankings - Fortune

Oct 06, 2026

Oct 05, 2026

Cytokinetics Falls as Investors Appear to Take Profits Despite Recent Aficamten Progress - Quiver Quantitative

Oct 05, 2026

Oct 04, 2026

CYTK6536068 Bond Profile: Coupon and Redemption - TradingView

Oct 04, 2026

Oct 03, 2026

Wells Fargo Maintains Cytokinetics(CYTK.US) With Buy Rating, Maintains Target Price $105 - Moomoo

Oct 03, 2026

Oct 03, 2026

Cytokinetics, Incorporated (CYTK) Stock Forecasts - Yahoo! Finance Canada

Oct 03, 2026

Oct 02, 2026

Cytokinetics Inc. Advanced Charts | CYTK - Barron's

Oct 02, 2026

Oct 02, 2026

Cytokinetics Announces Four Presentations at HFSA 2026 Highlighting Aficamten Data in Hypertrophic Cardiomyopathy - Quiver Quantitative

Oct 02, 2026